JPMORGAN CHASE & CO - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 152 filers reported holding AKERO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,143,355
+129.5%
714,578
+111.8%
0.00%
+100.0%
Q2 2023$15,749,472
+94.7%
337,320
+59.5%
0.00%
+100.0%
Q1 2023$8,091,000
+80439.5%
211,468
+15.4%
0.00%0.0%
Q4 2022$10,046
-99.9%
183,315
-22.2%
0.00%0.0%
Q3 2022$8,020,000
+261.4%
235,529
+0.3%
0.00%
Q2 2022$2,219,000
+240.9%
234,827
+412.0%
0.00%
Q1 2022$651,000
-35.6%
45,867
-4.1%
0.00%
Q4 2021$1,011,000
-7.3%
47,824
-2.1%
0.00%
Q3 2021$1,091,000
-13.8%
48,830
-4.2%
0.00%
Q2 2021$1,265,000
-9.3%
50,969
+6.1%
0.00%
Q1 2021$1,394,000
+16.1%
48,036
+3.2%
0.00%
Q4 2020$1,201,000
-34.2%
46,545
-20.0%
0.00%
Q3 2020$1,826,000
+15.6%
58,184
-8.3%
0.00%
Q2 2020$1,580,000
+45.5%
63,421
+23.8%
0.00%
Q1 2020$1,086,000
-53.7%
51,249
-51.5%
0.00%
Q4 2019$2,347,000
+22.8%
105,730
+25.9%
0.00%
Q3 2019$1,911,00083,9670.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders